Unimark Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IMIPENEM USP (STERILE), with a corresponding US DMF Number 28356.
Remarkably, this DMF maintains an Active status since its submission on June 16, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 04, 2014, and payment made on July 10, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II